1. Home
2. Quality Improvement
3. Lipid QI Programme
4. Module 4

Lipid Quality Improvement (QI) Programme

Module 4: Familial Hypercholesterolaemia and Genetic Lipid Disorders

This programme has been solely funded by Novartis. Novartis were not involved in the development of the programme, content, selection of speakers or their arrangements. All content has been independently developed by PCCS.

These modules were filmed in November 2023, which was prior to the publication of the updated NICE guideline NG238. As a result, throughout the videos reference is made to NICE CG181.

The information provided in this presentation is for educational purposes only. Prescribing or management decisions made by clinicians are exclusively their own responsibility. The speaker/PCCS bear no responsibility regarding management or prescribing decisions made by others, or otherwise.